Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 4, 2009International Archives of Allergy and Immunology

The Immunopathology of Psoriasis

View Full Paper
Ask AI
Bookmark
Share

Authors

ECE ChristophersKiel University

Discussion

Loading...

Member takes

Overview

Review reveals distinct immunogenetic pathways and aberrant mediator expression in psoriasis patients, highlighting shared mechanisms with other chronic relapsing T-cell disorders.

Key Points

  • To review the immunopathological mechanisms, genetic factors, and cellular pathways driving different clinical phenotypes of psoriasis.
  • Characterized immunogenetic variations between early-onset (type I) and pustular subtypes of psoriasis.
  • Evaluated the role of cellular infiltration, genetic susceptibility loci, and molecular inflammatory mediators.
  • Type I early-onset psoriasis exhibits epidermal hyperproliferation, intraepidermal polymorphs, and strong genetic links to MHC class I haplotypes.
  • T-cell activation drives aberrant upregulation of regulatory cytokines, growth factors, and inflammatory lipid mediators.
  • Immunopathogenetic pathways in psoriasis show direct mechanistic parallels with chronic relapsing T-cell diseases such as Crohn's disease and rheumatoid arthritis.

Cite This Study

E Christophers (2009) studied this question.

synapsesocial.com/papers/6a7a678974c579e25f892e90https://doi.org/10.1159/000237288
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1A Multifaced Approach on Psoriasis Pathogenesis2024 · 1 citations
  2. 2Review: A Contemporary, Multifaced Insight into Psoriasis Pathogenesis2024 · 24 citations
  3. 3Controversial Issues of Immunopathogenesis of Psoriasis and Atopic Dermatitis2024 · 1 citations
  4. 4Exploring Immune-genomic and Biomarker Insights in Psoriasis: Pathology of Disease and Treatment Advances2025
  5. 5Skin immune microenvironment in psoriasis: from bench to bedside2025